Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 151-160 of 411 for multiple

Edit search filters
  1. A Trial To Evaluate The Efficacy And Safety Of Reldesemtiv In Patients With Amyotrophic Lateral Sclerosis (ALS)

    Jacksonville, FL

  2. Percutaneous Spinal Stimulation in Participants with Multiple Sclerosis

    Rochester, MN

  3. A Study Of CART-TnMUC1 In Patients With TnMUC1-Positive Advanced Cancers

    Scottsdale/Phoenix, AZ

  4. Prospective Study of Round Window Versus Cochleostomy Approach to CI Surgery

    Rochester, MN

  5. A Study Of Rifampicin In Multiple System Atrophy

    Jacksonville, FL, Rochester, MN

  6. Treatment Of Participants With Primary Or Secondary Progressive Multiple Sclerosis

    Rochester, MN

  7. An Efficacy And Safety Study Of Palovarotene For The Treatment Of MO

    Rochester, MN

  8. Horizon Two Adaptive Platform Study In High Risk Newly Diagnosed Multiple Myeloma

    Rochester, MN

  9. A Study Of Subcutaneous Daratumumab Versus Active Monitoring In Participants With High-Risk Smoldering Multiple Myeloma

    Rochester, MN

  10. Early Intensive Versus Escalation Approaches For Relapsing-Remitting Multiple Sclerosis Long Term Extension

    Rochester, MN

.

Mayo Clinic Footer